Back to search

Acute myocardial infarction during treatment with an activated prothrombin complex concentrate in a patient with Factor VIII deficiency and a factor VIII inhibitor

Data up to Jan 2025

Published1988
Citations81
References35

Total Citations Per Year

Abstract

References (35)

The Effect of Activated Prothrombin-Complex Concentrate (FEIBA) on Joint and Muscle Bleeding in Patients with Hemophilia A and Antibodies to Factor VIII

1981 • 303 citations

Thrombosis or Myocardial Infarction in Congenital Clotting Factor Abnormalities and Chronic Thrombocytopenias

1983 • 189 citations

The use of factor eight inhibitor by-passing activity (FEIBA immuno) product for treatment of bleeding episodes in hemophiliacs with inhibitors

1983 • 182 citations

Recording the Size of Thyroid Nodules

1973 • 120 citations

Intravascular Coagulation with Use of Human Prothrombin Complex Concentrates

1976 • 91 citations

Thromboembolic Complications

1975 • 91 citations

The effect of activated prothrombin-complex concentrate (FEIBA) on joint and muscle bleedings in patients with haemophilia A with an inhibitor to Factor VIII

1982 • 90 citations

Pathophysiology of Acute Myocardial Infarction, 1981

1981 • 86 citations

Postoperative Thromboses in Hemophilia B

1973 • 83 citations

Prothrombin Concentrates in Treatment of Christmas Disease and Allied Disorders

1969 • 57 citations

Myocardial Infarction After Factor IX Therapy

1981 • 55 citations

Infection and infarction. Acute viral (and other) infection in the onset, pathogenesis, and mimicry of acute myocardial infarction

1986 • 51 citations

Fatal Myocardial Infarction Following Therapy with Prothrombin Complex Concentrates in a Young Man with Hemophilia A

1984 • 50 citations

Hemophilia in the Child and Adult

1990 • 44 citations

Heparin for Common-Duct Stone (Cont.)

1973 • 43 citations

Acute myocardial infarction in a young hemophiliac patient during therapy with Factor IX concentrate and epsilon aminocaproic acid

1981 • 42 citations

Laboratory evidence of DIC under FEIBA treatment of a hemophilic patient with intracranial bleeding and high titre factor VIII inhibitor

1981 • 40 citations

Therapy with Factor IX Concentrate Resulting in DIC and Thromboembolic Phenomena

1978 • 33 citations

Use of Prothrombin Complex Concentrates in Hemophiliacs with Inhibitors: Clinical and Laboratory Studies

1978 • 32 citations

Vascular Lesions in Hemophilia B

1973 • 27 citations

Summary Report and Recommendations of the Task Force Members and Consultants

1975 • 26 citations

Angiographic evidence of hemorrhagic myocardial infarction after intracoronary thrombolysis with streptokinase

1983 • 24 citations

A Survey of the Effectiveness of Prothrombin Complex Concentrates in Controlling Hemorrhage in Patients with Hemophilia and Anti-Factor VIII Antibodies

1980 • 22 citations

Activated F IX Concentrate (FEIBA) Used in the Treatment of Haemophilic Patients with Antibody to F VIII

1978 • 21 citations

Hemophilia in the Child and Adult

1989 • 20 citations

Increased Fibrinopeptide A after Prothrombin Complex Concentrates

1980 • 18 citations

Treatment of inhibitor patients with activated prothrombin complex concentrates.

1984 • 18 citations

Early experience with the use of anti-inhibitor coagulant complex to treat bleeding in hemophiliacs with inhibitors to factor VIII.

1987 • 17 citations

Factor IX and thrombosis

1977 • 13 citations

Notfallbehandlung von Blutungskomplikationen bei Hemmkörper-Hämophilie mit aktivierten Prothrombinkomplex-Konzentraten

1977 • 11 citations

Coronary Artery Spasm, Coronary Artery Thrombosis, and Myocardial Infarction

1981 • 11 citations

Activated Prothrombin Complex Concentrates. Managing Hemophilia with Factor VIII Inhibitor.

1983 • 7 citations

Inhibitor treatment using unactivated prothrombin complex concentrates: the Pennsylvania experience--1978-1982.

1984 • 6 citations

Complications of Therapy in Hemophilia

1984 • 4 citations

Complications of therapy in hemophilia.

1984 • 3 citations

Cited By (0)

Loading...